Banović, M., Mahovlić, V., Meljanac Salopek, K., Banović, V., Babić, I., Orešković, S. & Babić, D. (2015). The value of HPV-HR DNA testing during the follow-up after treatment of CIN3/AIS. Pathology Oncology Research, 21. (3), 613-617. doi: 10.1007/s12253-014-9865-8
Banović, Maja, et al. "The value of HPV-HR DNA testing during the follow-up after treatment of CIN3/AIS." Pathology Oncology Research, vol. 21, no. 3, 2015, pp. 613-617. https://doi.org/10.1007/s12253-014-9865-8
Banović, Maja, Vesna Mahovlić, Kristina Meljanac Salopek, Vladimir Banović, Ivan Babić, Slavko Orešković and Damir Babić. "The value of HPV-HR DNA testing during the follow-up after treatment of CIN3/AIS." Pathology Oncology Research 21, no. 3 (2015): 613-617. https://doi.org/10.1007/s12253-014-9865-8
Banović, M., et al. (2015) 'The value of HPV-HR DNA testing during the follow-up after treatment of CIN3/AIS', Pathology Oncology Research, 21(3), pp. 613-617. doi: 10.1007/s12253-014-9865-8
Banović M, Mahovlić V, Meljanac Salopek K, Banović V, Babić I, Orešković S, and sur.. The value of HPV-HR DNA testing during the follow-up after treatment of CIN3/AIS. Pathology Oncology Research [Internet]. 2015 July [cited 2024 November 06];21(3):613-617. doi: 10.1007/s12253-014-9865-8
M. Banović, et al., "The value of HPV-HR DNA testing during the follow-up after treatment of CIN3/AIS", Pathology Oncology Research, vol. 21, no. 3, pp. 613-617, July 2015. [Online]. Available at: https://urn.nsk.hr/urn:nbn:hr:105:962244. [Accessed: 06 November 2024]